<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04640753</url>
  </required_header>
  <id_info>
    <org_study_id>031.GID.2018.D</org_study_id>
    <nct_id>NCT04640753</nct_id>
  </id_info>
  <brief_title>Peroral Endoscopic Myotomy for the Treatment of Achalasia</brief_title>
  <official_title>Peroral Endoscopic Myotomy for the Treatment of Achalasia: A Single-center Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Methodist Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Methodist Health System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There will be a retrospective chart review for patients who underwent endoscopic procedures&#xD;
      and POEM from 06/2016 - 01/2019 &amp; a prospective chart review will be performed for patients&#xD;
      who will undergo endoscopic procedures and POEM from 02/2019 - 06/2021&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects will undergo no additional tests and procedures as part of this study. All data will&#xD;
      be collected from patient's electronic health records (EHR) of the hospital In addition; a&#xD;
      prospective chart review will be performed for patients who will undergo endoscopic&#xD;
      procedures and POEM from 02/2019 - 06/2021. All the subjects enrolled in prospective chart&#xD;
      review will be first consented for their study participation. Subjects will undergo a&#xD;
      clinically indicated endoscopic procedure and POEM and subsequent follow-up clinical visits&#xD;
      as part of their standard medical care. All procedures, barring research activities such as&#xD;
      consenting and data collection from Electronic Health Records, will be either clinically&#xD;
      indicated and/or standard of care.&#xD;
&#xD;
        -  Each patient in the study will be assigned a Case ID number to de-identify their&#xD;
           personal health information during data collection&#xD;
&#xD;
        -  The Case ID number connecting the patient to the personal health information will be in&#xD;
           an encrypted electronic file on a computer that can only be accessed by study members at&#xD;
           MDMC.&#xD;
&#xD;
        -  A procedure report and outpatient clinical records for each subject's POEM procedure&#xD;
           will be used to record each patient's data for the registry&#xD;
&#xD;
        -  That data will only be shared by members of the study (PIs, research coordinator) who&#xD;
           require it for conducting of data collection/interpretation&#xD;
&#xD;
      &quot;Disclaimer: Any cost associated with the procedures stated herein will be billed directly to&#xD;
      you or to your insurance (as applicable).&quot;&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 6, 2019</start_date>
  <completion_date type="Anticipated">February 5, 2023</completion_date>
  <primary_completion_date type="Anticipated">February 5, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Decrease or no symptoms of chest pain</measure>
    <time_frame>upto 180 days</time_frame>
    <description>To continue and review our treatment outcomes, patient safety in cases with achalasia, we follow up after the procedure up to 180 days. Follow-up period varies from patient to patient.</description>
  </primary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Achalasia</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endoscopic procedure for achalasia</intervention_name>
    <description>POEM procedure will have a high technical feasibility, with effective clinical resolution of symptoms both in the short and long term.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        There will be a retrospective chart review for patients who underwent endoscopic procedures&#xD;
        and POEM from 06/2016 - 01/2019. In addition; a prospective chart review will be performed&#xD;
        for patients who will undergo endoscopic procedures and POEM from 02/2019 - 06/2021.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Any discharged patient who has undergone clinically indicated and/or standard of care&#xD;
             POEM for the treatment of Achalasia from 6/2016 to 6/2021.&#xD;
&#xD;
          -  Above or equal to 18 years of age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any patient who has not undergone POEM for the treatment of Achalasia.&#xD;
&#xD;
          -  Below 18 years of age&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Prashant Kedia, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Methodist Dallas Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Crystee Cooper, DHEd</last_name>
    <phone>214-947-1280</phone>
    <email>clinicalresearch@mhd.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zaid Haddadin, MS</last_name>
    <phone>214-947-4604</phone>
    <email>ClinicalResearch@mhd.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Methodist Dallas Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Prashant Kedia, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 27, 2019</study_first_submitted>
  <study_first_submitted_qc>November 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 23, 2020</study_first_posted>
  <last_update_submitted>November 9, 2021</last_update_submitted>
  <last_update_submitted_qc>November 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esophageal Achalasia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

